Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.
Centroflora CMS, a joint venture between phytochemicals expert Centroflora from Brazil and the Swiss contract manufacturing organization (CMO) CMS Pharma, won the CPhI 2015 award for excellence in partnering and outsourcing for the way it handled its acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio in 2014. Andrew Badrot, founder and CEO of Centroflora CMS, discussed the project with Pharmaceutical Technology.
